>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Amplitude (AMPL) upgraded to Overweight from Sector Weight at KeyBanc Capital Markets; tgt $15
    • Cardinal Health (CAH) upgraded to Equal Weight from Underweight at Wells Fargo; tgt raised to $127
    • Centene (CNC) upgraded to Buy from Neutral at UBS; tgt raised to $80
    • Century Communities (CCS) upgraded to Neutral from Underweight at JP Morgan; tgt lowered to $97
    • Ciena (CIEN) upgraded to Buy from Neutral at BofA Securities; tgt raised to $95
    • Salesforce (CRM) upgraded to Overweight from Sector Weight at KeyBanc Capital Markets; tgt $440
  • Downgrades:
    • 8x8 (EGHT) downgraded to Underperform from Neutral at Mizuho; tgt lowered to $2.50
    • Boundless Bio (BOLD) downgraded to Neutral from Buy at Guggenheim
    • D.R. Horton (DHI) downgraded to Underweight from Neutral at JP Morgan; tgt lowered to $156
    • Editas Medicine (EDIT) downgraded to Hold from Buy at Stifel; tgt lowered to $3
    • Editas Medicine (EDIT) downgraded to Hold from Buy at Truist
    • TopBuild (BLD) downgraded to Neutral from Buy at Seaport Research Partners
  • Others:
    • ADTRAN (ADTN) initiated with a Neutral at ODDO BHF
    • Advance Auto (AAP) initiated with a Market Perform at BMO Capital Markets; tgt $45
    • AES (AES) initiated with a Buy at HSBC Securities; tgt $17
    • American Eagle (AEO) initiated with a Mkt Perform at Raymond James
    • Atmos Energy (ATO) resumed with a Buy at BofA Securities; tgt $156
    • AutoZone (AZO) initiated with an Outperform at BMO Capital Markets; tgt $3700
    • Benitec Biopharma (BNTC) initiated with an Outperform at Robert W. Baird; tgt $30
    • Canadian Solar (CSIQ) initiated with an Outperform at Mizuho; tgt $20
    • Cidara Therapeutics (CDTX) initiated with an Outperform at RBC Capital Mkts; tgt $34
    • Coty (COTY) initiated with a Neutral at Goldman; tgt $9
    • Dyne Therapeutics (DYNE) initiated with an Outperform at Robert W. Baird; tgt $46
    • e.l.f. Beauty (ELF) initiated with a Buy at Goldman; tgt $165
    • Enliven Therapeutics (ELVN) initiated with a Buy at BTIG Research; tgt $42
    • Expedia Group (EXPE) initiated with a Hold at CICC